AU Patent

AU2013202665B2 — Oral formulations of cytidine analogs and methods of use thereof

Assigned to Celgene Corp · Expires 2015-06-25 · 11y expired

What this patent protects

A pharmaceutical composition for oral administration comprising a therapeutically effective amount of 5-azacytidine, wherein the composition releases the 5- azacytidine substantially in the stomach following oral administration to a subject.

USPTO Abstract

A pharmaceutical composition for oral administration comprising a therapeutically effective amount of 5-azacytidine, wherein the composition releases the 5- azacytidine substantially in the stomach following oral administration to a subject.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013202665B2
Jurisdiction
AU
Classification
—
Expires
2015-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Celgene Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.